Cargando…
Coagulopathy during COVID-19 infection: a brief review
The COVID-19 pandemic caused by SARS-CoV-2 continues to spread rapidly due to its virulence and ability to be transmitted by asymptomatic infected persons. If they are present, the symptoms of COVID-19 may include rhinorrhea (runny nose), headache, cough, and fever. Up to 5% of affected persons may...
Autores principales: | Cunningham, Robin M., Johnson Moore, Kyle L., Moore, Jacen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483403/ https://www.ncbi.nlm.nih.gov/pubmed/36121504 http://dx.doi.org/10.1007/s10238-022-00891-4 |
Ejemplares similares
-
Coagulopathy in COVID-19
por: Lio, Ka U, et al.
Publicado: (2021) -
Thrombosis and coagulopathy in COVID‐19: An illustrated review
por: Levi, Marcel, et al.
Publicado: (2020) -
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020) -
The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020) -
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020)